JULY SPECIAL! 21 Blend Combo Sampler (Save 55%) $1740 value for $777! Comes with Interstellar Mug!
March 30, 2019
Peel & Spice Combo 200:1
July 1, 2019
LUTEOLIN 200:1
$250.00
LUTEOLIN
Top candidates at fighting coronoavirus: LUTEOLIN.
Cytotoxic inhibitors of Hsp90 are the ONLY cancer chemotherapeutic agents known to impact all six hallmarks of cancer simultaneously. As defined by Hanahan and Weinberg, this includes:
1) self-sufficiency in growth signals,
2) insensitivity to antigrowth signals,
3) evasion of apoptosis,
4) limitless replicative potential,
5) sustained angiogenesis, and
6) tissue invasion/metastasis.
*This study indicated that LUTEOLIN may act as a potent HSP90 inhibitor in antitumor strategies.
- Luteolin Reduces Alzheimer’s Disease Pathologies Induced by Traumatic Brain Injury
- PEA and Luteolin synergistically reduce mast cell-mediated toxicityand elicit neuroprotection in cell-based models of brain ischemia
- Neuroprotection of LuteolinAgainst Aβ_(25-35) Induced Neural Damage
- Luteolin downregulates TLR4, TLR5, NF-κB and p-p38MAPK expression, upregulates the p-ERK expression, and protects rat brains against focal ischemia
- Luteolin reduced the traumatic brain injury-induced memory impairments in rats: Attenuating oxidative stress and dark neurons of Hippocampus
- Ameliorating effect of Luteolin on memory impairment in an Alzheimer’s disease model
- Erratum to: A new co-ultramicronized composite including palmitoylethanolamide and Luteolin to prevent neuroinflammation in spinal cord injury
- The effects of C-glycosylation of Luteolin on its antioxidant, anti-Alzheimer’s disease, anti-diabetic, and anti-inflammatory activities
- Neuroprotection by Association of Palmitoylethanolamide with Luteolin in Experimental Alzheimer’s Disease Models: The Control of Neuroinflammation
- Simultaneous electroanalytical determination of Luteolin and rutin using artificial neural networks
- Luteolin as a potential preventive and therapeutic candidate for Alzheimer’s disease
- Luteolin Exerts Neuroprotective Effect by Up-regulation of HO-1 via JNK Pathway in Primary Cultured Rat Cortical Cells
- Postischemic administration of liposome-encapsulated Luteolin prevents against ischemia-reperfusion injury in a rat middle cerebral arteryocclusion model
- Neurotrophic and Cytoprotective Action of Luteolin in PC12 Cells through ERK-Dependent Induction of Nrf2-Driven HO-1 Expression
- Neuroprotective effect of Luteolin on amyloid β protein (25–35)‐induced toxicity in cultured rat cortical neurons
- Brain Inflammation, Neuropsychiatric Disorders, and Immunoendocrine Effects of Luteolin
- Luteolin promotes long-term potentiation and improves cognitive functions in chronic cerebral hypoperfused rats
- Protective role of Luteolin against cognitive dysfunction induced by chronic cerebral hypoperfusion in rats
- Luteolin as an anti-inflammatory and neuroprotective agent: A brief review
- Protective effects of Luteolin against cognitive impairment induced by infusion of Aβ peptide in rats
- The anti-amnesic effects of Luteolin against amyloid β25–35 peptide-induced toxicity in mice involve the protection of neurovascular unit
- Luteolin protects against high fat diet-induced cognitive deficits in obesity mice
- Luteolin from Purple Perilla mitigates ROS insult particularly in primary neurons
- Pharmacodynamic Effect of Luteolin Micelles on Alleviating Cerebral Ischemia Reperfusion Injury
- Luteolin Reduces Zinc-Induced Tau Phosphorylation at Ser262/356 in an ROS-Dependent Manner in SH-SY5Y Cells
- Dietary Luteolin Reduces Proinflammatory Microglia in the Brain of Senescent Mice
- Effects of Luteolin onlearning acquisition in rats: Involvement of the central cholinergic system
- Luteolin Inhibits Microglial Inflammation and Improves Neuron Survival Against Inflammation
- Luteolin reduces primary hippocampal neurons death induced by neuroinflammation
- Luteolin improves the impaired nerve functions in diabetic neuropathy: behavioral and biochemical evidences
- Neuroprotective effects of Luteolin against apoptosis induced by 6-hydroxydopamine on rat pheochromocytoma PC12 cells
- Luteolin Inhibits Microglia and Alters Hippocampal-Dependent Spatial Working Memory in Aged Mice
- Luteolin protects the hippocampus against neuron impairments induced by kainic acid in rats
- Protective properties of quercetin and Luteolin from Petasites japonicus leaves against Aβ (25–35)-induced neurotoxicity in B103 cells
- Therapeutic potential of Luteolin in transgenic Drosophila model of Alzheimer’s disease
- Luteolin Could Improve Cognitive Dysfunction by Inhibiting Neuroinflammation
- Cellular uptake of quercetin and Luteolin and their effects on monoamine oxidase-A in human neuroblastoma SH-SY5Y cells
- Luteolin attenuates neuronal apoptosis in the hippocampi of diabetic encephalopathy rats
- The protective effect of Luteolin on amyloid β protein (25–35)-induced neurotoxicity in primary rat cortical neuron cells and possible mechanisms
- Additive Protective Effects of Luteolin and Pyruvate against 6-Hydroxydopamine and 3-Hydroxykynurenine Induced Neurotoxicity in SH-SY5Y Cells
- Bioavailability and Pharmaco-therapeutic Potential of Luteolin in Overcoming Alzheimer’s Disease
- A new therapeutic target for Alzheimer’s disease: effects of palmitoylethanolamide with Luteolin association on neuroinflammation pathway (845.10)
- The combination of Luteolin and l-theanine improved Alzheimer disease–like symptoms by potentiating hippocampal insulin signaling and decreasing neuroinflammation and norepinephrine degradation in amyloid-β–infused rats
- Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2–ARE pathway
- Effects of intrathecal and intracerebroventricular administration of Luteolin in a rat neuropathic pain model
- Effects of Luteolinon spatial memory, cell proliferation, and neuroblast differentiation in the hippocampal dentate gyrus in a scopolamine-induced amnesia model
- Neuroprotection ofLuteolin against methylmercury-induced toxicity in lobster cockroach Nauphoeta cinerea
- Luteolin induces hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome
- Co-Ultramicronized Palmitoylethanolamide/Luteolin Promotes Neuronal Regeneration after Spinal Cord Injury
- Luteolin Protected against Beta-Amyloid-induced Neuronal Cell Death and Memory Impairment via Activation of Nrf2-HO-1 Signaling Pathway
- A new co-ultramicronized composite including palmitoylethanolamide and Luteolin to prevent neuroinflammation in spinal cord injury
- Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
- Sa1967 The Effect of Flavonoids Luteolin and Quercetin Upon Colon Cancer Cells In Vitro; “So What’s in Your Fiber?”
- Protective role of Luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis
- Anti-tumor promoting potential of Luteolin against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats
- Dose- and Time-Dependent Effects of Luteolin on Liver Metallothioneins and Metals in Carbon Tetrachloride-Induced Hepatotoxicity in Mice
- Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model
- Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I
- Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells
- Luteolin Induces Apoptosis in Oral Squamous Cancer Cells
- Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/ β-catenin pathway
- The Effect of Luteolin on Lymphocyte Cells In Leukemia Patient
- Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound Luteolin
- Luteolin Inhibits Protein Kinase Cε and c-Src Activities and UVB-Induced Skin Cancer
- Anti-carcinogenic Effects of the Flavonoid Luteolin
- Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells
- The combination of TRAIL and Luteolin enhances apoptosis in human cervical cancer HeLa cells
- Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin
- Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid Luteolin in human epithelioid cancer cells
- Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells
- A Critical Role of Luteolin-Induced Reactive Oxygen Species in Blockage of Tumor Necrosis Factor-Activated Nuclear Factor-κB Pathway and Sensitization of Apoptosis in Lung Cancer Cells
- Cytochrome P450 CYP1 metabolism of hydroxylated flavones and flavonols: Selective bioactivation of Luteolin in breast cancer cells.
- Anti-cancer Effects of Luteolin and Its Novel Mechanism in HepG2 Hepatocarcinoma Cell
- Luteolin, a novel natural inhibitor of TPL2 kinase, inhibits tumor necrosis factor-α-induced cyclooxygenase-2 expression in JB6 mouse epidermis cells
- Anti-tumor mechanisms of Luteolin, a major Flavonoid oF Chrysanthemum Morifolium
- Luteolin Suppresses Proliferation of Choriocarcinoma Cells through Regulating PI3K/AKT Signaling Pathway and Blocking Transcriptional Activity of SREBP1
- Anti-proliferative and chemosensitizing effects of Luteolin on human gastric cancer AGS cell line
- Sensitizing HER2-overexpressing cancer cellsto Luteolin-induced apoptosis through suppressing p21WAF1/CIP1 expression with rapamycin
- Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells
- Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: a review.
- Synergistic apoptotic effect of celecoxib and Luteolin on breast cancer cells
- Molecular targets of Luteolin in cancer
- Luteolin Induces Growth Arrest in Colon Cancer Cells Through Involvement of Wnt/β-Catenin/GSK-3β Signaling
- Characteristic rat tissue accumulation of nobiletin, a chemopreventive polymethoxyflavonoid, in comparison with Luteolin
- Luteolin Inhibits Proliferation Induced by IGF-1 Pathway Dependent ERα in Human Breast Cancer MCF-7 Cells
- Effects of dietary flavonoids, Luteolin, and quercetin on the reversal of epithelial–mesenchymal transition in A431 epidermal cancer cells
- Luteolin attenuates TGF-β1-induced epithelial–mesenchymal transition of lung cancer cells by interfering in the PI3K/Akt–NF-κB–Snail pathway
- Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3
- The dietary flavonoid Luteolin inhibits Aurora B kinase activity and blocks proliferation of cancer cells
- Serum Concentration of Genistein, Luteolin and Colorectal Cancer Prognosis
- Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway.
- Cancer Chemopreventive Potential of Luteolin-7-O-Glucoside Isolated From Ophiorrh
- Proteomic identification of anti-cancer proteins in Luteolin-treated human hepatoma Huh-7 cells
- Luteolin, a bioflavonoid inhibits Azoxymethane-induced colorectal cancer through activation of Nrf2 signaling
- Luteolin suppresses growth and migration of human lung cancer cells
- Response of Myeloid Leukemia Cells to Luteolin is Modulated by Differentially Expressed Pituitary Tumor-Transforming Gene 1 (PTTG1) Oncoprotein
- Luteolininduces apoptosis in multidrug resistant cancer cellswithout affecting the drug transporter function: Involvement of cell line‐specific apoptotic mechanisms
- Luteolin, ellagic acid and punicic acid are natural products that inhibit prostate cancer metastasis
- Luteolin Inhibits Breast Cancer Development and Progression In Vitro and In Vivo by Suppressing Notch Signaling and Regulating MiRNAs
- Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells
- Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells
- Combination of oncolytic adenovirus and Luteolin exerts synergistic antitumor effects in colorectal cancer cells and a mouse model
- Targeted Luteolin Delivery via Bevacizumab-Modified Polymer Microbubbles to Colon Cancer Cells
- Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer
- Luteolin enhances TNF-related apoptosis-inducing ligand’s anticancer activity in a lung cancer xenograft mouse model
- Luteolin Regulation of Estrogen Signaling and Cell Cycle Pathway Genes in MCF-7 Human Breast Cancer Cells
- Luteolin as a glycolysis inhibitor offers superior efficacy and lesser toxicity of doxorubicin in breast cancer cells
- Luteolin induces apoptotic cell death through AIF nuclear translocation mediated by activation of ERK and p38 in human breast cancer cell lines
- Radiosensitization effect of Luteolin on human gastric cancer SGC-7901 cells.
- Extra precision Docking studies of novel Luteolin analogues for the inhibition of Tankyrase II- “a theoretical based approach towards novel cancer target
- The Influence of Luteolin on Schultz-Dale Response in Animals
- Luteolin Attenuates Doxorubicin-Induced Cytotoxicity to MCF-7 Human Breast Cancer Cells
- Gefitinib and Luteolin Cause Growth Arrest of Human Prostate Cancer PC-3 Cells via Inhibition of Cyclin G-Associated Kinase and Induction of miR-630
- Luteolin Induces Apoptosis by Up-regulating miR-34a in Human Gastric Cancer Cells
- Luteolin sensitises drug-resistant human breast cancer cells to tamoxifen via the inhibition of cyclin E2 expression
- Luteolin 8-C-β-fucopyranoside inhibits invasion and suppresses TPA-induced MMP-9 and IL-8 via ERK/AP-1 and ERK/NF-κB signaling in MCF-7 breast cancer cells
- Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts
- Inhibition of hypoxia-induced epithelial mesenchymal transition by Luteolin in non-small cell lung cancer cells
- Luteolin Suppresses Cancer Cell Proliferation by Targeting Vaccinia-Related Kinase 1
- EBV reactivation as a target of Luteolin to repress NPC tumorigenesis
- Luteolin Induces Cell Cycle Arrest and Apoptosis Through Extrinsic and Intrinsic Signaling Pathways in MCF-7 Breast Cancer Cells
- Luteolin is effective in thenon-small cell lung cancer model with L858R/T790MEGF receptor mutation anderlotinib resistance
- Molecular mechanisms of Luteolin-7-O-glucoside-induced growth inhibition on human liver cancer cells: G2/M cell cycle arrest and caspase-independent apoptotic signaling pathways
- Breast Cancer Resistance Protein-Mediated Efflux of Luteolin Glucuronides in HeLa Cells Overexpressing UDP-Glucuronosyltransferase 1A9
- Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells
- Proteomic analysis reveals ATP-dependent steps and chaperones involvement in Luteolin–induced lung cancer CH27 cell apoptosis
- Epithelial‐to‐Mesenchymal Transition in Paclitaxel‐Resistant Ovarian Cancer Cells Is Downregulated by Luteolin
- Luteolin and gefitinib regulation of EGF signaling pathway and cell cycle pathway genes in PC-3 human prostate cancer cells
- Luteolin induces apoptotic cell death via antioxidant activity in human colon cancer cells
- [Effect of Luteolin and its combination with chemotherapeutic drugs on cytotoxicity of cancer cells].
- Luteolin Impacts on the DNA Damage Pathway in Oral Squamous Cell Carcinoma
- Luteolin: Anti-breast Cancer Effects and Mechanisms
- Luteolin inhibited proliferation and induced apoptosis of prostate cancer cellsthrough miR-301
- Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells
- A Superoxide-Mediated Mitogen-Activated Protein Kinase Phosphatase-1 Degradation and c-Jun NH2-Terminal Kinase Activation Pathway for Luteolin–Induced Lung Cancer Cytotoxicity
- Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer Cells
- Luteolin exerts an anticancer effect on NCI-H460 human non-small cell lung cancer cells through the induction of Sirt1-mediated apoptosis
- Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1
- Synergistic effect between celecoxib and Luteolin is dependent on estrogen receptor in human breast cancer cells
- Luteolin suppresses angiogenesis and vasculogenic mimicry formation through inhibiting Notch1-VEGF signaling in gastric cancer
- Luteolin acts as a radiosensitizer in non‑small cell lung cancer cells by enhancing apoptotic cell death through activation of a p38/ROS/caspase cascade
- Regulation of cell cycle and RNA transcription genes identified by microarray analysis of PC-3 human prostate cancer cells treated with Luteolin
- Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression
- Attenuating Smac mimetic compound 3‐induced NF‐κB activation by Luteolin leads to synergistic cytotoxicity in cancer cells
- Luteolin Induces Apoptosis in BE Colorectal Cancer Cells by Downregulating Calpain, UHRF1, and DNMT1 Expressions
- Inhibitory effect of Luteolin on the proliferation of human breast cancer cell lines induced by epidermal growth factor.
- Luteolin induces N-acetylation and DNA adduct of 2-aminofluorene accompanying N-acetyltransferase activity and gene expression in human bladder cancer T24 cell line.
- Inhibition of ANO1 by Luteolin and its cytotoxicity in human prostate cancer PC-3 cells
- Luteolin induces apoptosis in vitro through suppressing the MAPK and PI3K signaling pathways in gastric cancer
- Anti-tumor effect of Luteolin is accompanied by AMP-activated protein kinase and nuclear factor-κB modulation in HepG2 hepatocarcinoma cells
- Cytochrome P450 CYP1 metabolism of hydroxylated flavones and flavonols: Selective bioactivation of Luteolin in breast cancer cells
- Luteolin potentiates the sensitivity of colorectal cancer cell lines to oxaliplatin through the PPARγ/OCTN2 pathway.
- Luteolin Overcomes Resistance to Benzyl Isothiocyanate- Induced Apoptosis in Human Colorectal Cancer HCT-116 Cells
- Main components of pomegranate, ellagic acid and Luteolin, inhibit metastasis of ovarian cancerby down-regulating MMP2 and MMP9
- Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway
- Inhibition of the metastatic progression of breast and colorectal cancer in vitro and in vivo in murine model by the oxidovanadium(IV) complex with Luteolin
- Modulatory effect of Luteolin on redox homeostasis and inflammatory cytokines in a mouse model of liver cancer
- Dietary flavonoids, Luteolin and quercetin, inhibit invasion of cervical cancer by reduction of UBE2S through epithelial–mesenchymal transition signaling
- Mechanism of metastasis suppression by Luteolin in breast cancer
- Luteolin induces apoptosis in mouse liver cancer cells through ROS mediatedpathway: A mechanistic investigation.
- Kaempherol and Luteolin Decrease Claudin-2 Expression Mediated by Inhibition of STAT3 in Lung Adenocarcinoma A549 Cells
- Anticancer effect of Luteolin is mediated by downregulation of TAM receptor tyrosine kinases, but not interleukin-8, in non-small cell lung cancer cells
- RPS12 increases the invasiveness in cervical cancer activatedby c-Myc and inhibited by the dietary flavonoids Luteolin and quercetin
- Luteolin inhibits colorectal cancer cell epithelial-to-mesenchymal transition by suppressing CREB1 expression revealed by comparative proteomics study
- Luteolin sensitizes human liver cancer cells to TRAIL‑induced apoptosis via autophagy and JNK‑mediated death receptor 5 upregulation
- Flavonoids Luteolin and Quercetin Inhibit RPS19 and contributes to metastasis of cancer cells through c-Myc reduction
- [Inhibitory effect of Luteolin on the angiogenesis of chick chorioallantoic membrane and invasion of breast cancer cells via downregulation of AEG-1 and MMP-2].
- Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p
- [Research progress on anti-tumor effects of Luteolin].
- Luteolin prevents UV-induced skin damage and MMP-1 activation by interfering with the P38-MAPK pathway and IL-20 release
- Luteolin and Gemcitabine Protect Against Pancreatic Cancer in an Orthotopic Mouse Model.
- Luteolin-Loaded Spion as a Drug Carrier for Cancer Cell In Vitro
- Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancerstemness revealed by comparative proteomics
- MiR-34a, as a suppressor, enhance the susceptibility of gastric cancer cell to Luteolin by directly targeting HK1
- Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier in Vitro
- Apigenin, Chrysin, and Luteolin Selectively Inhibit Chymotrypsin-Like and Trypsin-Like Proteasome Catalytic Activities in Tumor Cells
- Consumption of the Dietary Flavonoids Quercetin, Luteolin and Kaempferol and Overall Risk of Cancer– A Review and Meta-Analysis of the Epidemiological Data
- Cuminum cyminum fruits as source of Luteolin-7-O-glucoside, potent cytotoxic flavonoid against breast cancer cell lines
- Luteolin exerts pro-apoptotic effect and anti-migration effects on A549 lung adenocarcinoma cellsthrough the activation of MEK/ERK signaling pathway
- Effects of Luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells.
- Effects of Luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis‐associated properties in A431 cells overexpressing epidermal growth factor receptor
- Inhibitory effect of Luteolin on hepatocyte growth factor/scatter factor–induced HepG2 cell invasion involving both MAPK/ERKs and PI3K–Akt pathways
- Protective effect of quercetin and Luteolin in human melanoma HMB-2 cells
- Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo
- Enhanced Anti-tumor Activity by the Combination of the Natural Compounds (−)-Epigallocatechin-3-gallate and Luteolin
- Protective role of Luteolin in 1,2‐dimethylhydrazine induced experimental colon carcinogenesis
- Luteolin prevents PDGF-BB-induced proliferation of vascular smooth muscle cellsby inhibition of PDGF β-receptor phosphorylation
- Luteolin Inhibits Human Prostate Tumor Growthby Suppressing Vascular Endothelial Growth Factor Receptor 2-Mediated Angiogenesis
- Chemoprotective effect of plant phenolics against anthracycline‐induced toxicity on rat cardiomyocytes. Part III. Apigenin, baicalelin, kaempherol, Luteolin and quercetin
- Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase–mediated p53 phosphorylation and stabilization
- Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt–GSK-3β–Cyclin D1 pathway
- Whitening activity of Luteolin related to the inhibition of cAMP pathway in α-MSH-stimulated B16 melanoma cells
- Chemopreventive potential of Luteolin during colon carcinogenesis induced by 1,2-dimethylhydrazine.
- Luteolin Nanoparticle in Chemoprevention: In Vitro and In Vivo Anticancer Activity
- Inhibitory effects of Luteolin isolated fromixeris sonchifolia hance on the proliferation of hepg2 human hepatocellular carcinoma cells
- Protective effects of Luteolin-7-glucoside against liver injury caused by carbon tetrachloride in rats
- Effect of Luteolin on the Levels of Glycoproteins During Azoxymethane-induced Colon Carcinogenesis in Mice
- Autophagy Inhibitor ChloroquineEnhanced the Cell Death Inducing Effect of the Flavonoid Luteolin in Metastatic Squamous Cell Carcinoma Cells
- Upregulation of prostate‐derived Ets factor by Luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells
- Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis
- Luteolin-loaded Phytosomes Sensitize Human Breast CarcinomaMDA-MB 231 Cells to Doxorubicin by Suppressing Nrf2 Mediated Signalling
- Luteolin reduces the invasive potential ofmalignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition
- The flavonoids diosmetin and Luteolinexert synergistic cytostatic effects in human hepatoma HepG2 cells via CYP1A-catalyzed metabolism, activation of JNK and ERK and P53/P21 up-regulation
- Luteolin–inhibited arylamine N-acetyltransferase activity and DNA–2-aminofluorene adduct in human and mouse leukemia cells
- Luteolin modulates expression of drug-metabolizing enzymes through the AhR and Nrf2 pathways in hepatic cells
- Luteolin enhances cholinergic activities in PC12 cells through ERK1/2 and PI3K/Akt pathways
- Luteolin, a flavonoid, as an anticancer agent: A review
- Luteolin suppresses colorectal cancer cell metastasis via regulation of the miR‑384/pleiotrophin axis
- Apoptosis induced by Luteolin in breast cancer: Mechanistic and therapeutic perspectives
- Abstract 4914: Luteolin inhibits metastasis of triple-negative breast cancer cells to the lungs
- Abstract 4159: Therapeutic effects of Luteolinagainst progestin-dependent breast cancer involves induction of apoptosis, and suppression of both stem-cell-like cells and angiogenesis
- EXPERIMENTAL STUDY OF ANTITUMOR AND CYTOKINES-MODULATING ACTIVITIES OF BISULFATE Luteolin AND Luteolin
- [Inhibitory effects of Luteolin on human gastric carcinoma xenografts in nude mice and its mechanism].
- Natural Polyphenols for Prevention and Treatment of Cancer
- 1067 POSTER Study of the Effects of Dietary Flavonoids, Luteolin and Quercetin on the Reversal of Epithelial-mesenchymal Transition in A431 Epidermal Cancer Cells
- Cyanidin-3-O-glucoside chloride acts synergistically with Luteolin to inhibit the growth of colon and breast carcinoma cells
- Synthesis of Luteolin loaded zein nanoparticles for targeted cancer therapy improving bioavailability and efficacy
- Growth inhibition of Luteolin on HepG2 cells is induced via p53 and Fas/Fas-ligand besides the TGF-β pathway
- Time-Dependent Metabolismof Luteolin by Human UDP-Glucuronosyltransferases and Its Intestinal First-Pass Glucuronidation in Mice
- Gas chromatographic/mass spectrometric profiling of Luteolin and its metabolites in rat urine and bile
- Diverse mechanisms of growth inhibition byLuteolin, resveratrol, and quercetin in MIA PaCa-2 cells: a comparative glucose tracer study with the fatty acid synthase inhibitor C75
- Hepatoprotective activity of luteolin isolated from A. millefolium on CCl4 intoxicated rat
- Inhibitory effects of Luteolin isolated fromixeris sonchifolia hance on the proliferation of hepg2 human hepatocellular carcinoma cells
- Cytotoxicity ofLuteolin in primary rat hepatocytes: the role of CYP3A‐mediated ortho‐benzoquinone metabolite formation and glutathione depletion
- Enhanced anticancer activity in vitroand in vivo of Luteolin incorporated into long‐circulating micelles based on DSPE‐PEG2000 and TPGS
- Selective Cytotoxicity of Luteolin and Kaempferol on Cancerous HepatocytesObtained from Rat Model of Hepatocellular Carcinoma: Involvement of ROS-Mediated Mitochondrial Targeting
- Raf and PI3K are the Molecular Targets for the Anti‐metastatic Effect ofLuteolin
- Study on inhibition of Luteolin on proliferation of human gastric cancer cell line BGC-823
- Modulation of G2/M cell cycle arrest and apoptosis by Luteolin in human colon cancer cells and xenografts
- Cytotoxic potential of Anisochilus carnosus (L.f.) wall and estimation of Luteolin content by HPLC
- Protective effects of three Luteolin derivatives on aflatoxin B1-induced genotoxicity on human blood cells
- In Silico Molecular Docking Studies of Rutin Compound against Apoptotic Proteins (Tumor Necrosis Factor, Caspase-3, NF-Kappa-B, P53, Collagenase, Nitric Oxide Synthase and Cytochrome C)
- Deciphering the molecular mechanism and apoptosis underlying the in‐vitro and in‐vivo chemotherapeutic efficacyof vanadium Luteolin complex in colon cancer
- Study on antitumor and antimetastatic effect of Luteolin
- Induction of cell cycle arrest and apoptosis inHT-29 human colon cancer cellsby the dietarycompound Luteolin
- Inhibitory effect of Luteolin and kaempferol on proliferation of human leukemic cell line HL-60 in vitro
- Luteolin suppresses tumor progression through lncRNA BANCR and its downstream TSHR/CCND1 signaling in thyroid carcinoma
- Luteolin enhances the cancer therapeutic effect of cisplatin in vitro and in vivo via stabilizing p53 protein
- Luteolin: A potential flavonoid for cancerous diseases
- Effect of Luteolin on glycoproteins metabolism in 1, 2-dimethylhydrazine induced experimental colon carcinogenesis.
- Luteolin ameliorates ferric nitrilotriacetic acid induced renal toxicity and tumor promotional response in rat
- In vitro study of molecular structure and cytotoxicity effect of Luteolin in the human colon carcinoma cells
- Abstract 1010: Synergistic antitumor effects of Luteolin and silibinin with overexpression of miR-7-1-3p inhibited autophagy and promoted apoptosis in glioblastoma
- 516 POSTER JNK-mediated p53 phosphorylation and stabilization contributes to the sensitization effect of Luteolin on the anti-cancer effect of cisplatin
- Luteolinenhances the antitumor activity of lapatinib in human breast cancer cells
- Evaluation of Luteolin in the Prevention of N-nitrosodiethylamine-induced Hepatocellular Carcinoma Using Animal Model System
- Phytochylomicron as a dual nanocarrier for liver cancer targetingof Luteolin: in vitro appraisal and pharmacodynamics
- Effects on Liver Lipid Metabolism of the Naturally Occurring Dietary Flavone Luteolin-7-glucoside
- Therapeutic and chemopreventive potential of Luteolin against growth and metastasis of breast cancer
- MicroRNA-6809-5p mediates Luteolin–induced anticancer effects against hepatoma by targeting flotillin 1
- [P8-192] High fat diet and Luteolin supplementation modulate breast tumor growth in C3H mice
- Anticancer activity of baicalein and Luteolin studied in colorectal adenocarcinoma LoVo cells and in drug-resistant LoVo/Dx cells
- Luteolin Promotes Degradation in Signal Transducer and Activator of Transcription 3 in Human Hepatoma Cells: An Implication for the Antitumor Potential of Flavonoids
- Flavonoids, taxifolin and Luteolin attenuate cellular melanogenesis despite increasing tyrosinase protein levels
- Luteolin and its inhibitory effect on tumor growthin systemic malignancies
- Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: Involvement of iNOS and COX-2
- The molecular mechanism of Luteolin-induced apoptosis is potentially related to inhibition of angiogenesis in human pancreatic carcinoma cells
- Anti-tumor activities of Luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented Luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo
- Antioxidant and antitumor efficacy of Luteolin, a dietary flavone on benzo(a)pyrene-induced experimental lung carcinogenesis
- Bovine serum albumin binding, antioxidant and anticancer properties of an oxidovanadium(IV) complex with Luteolin
- Luteolin, a Novel Natural Inhibitor of Tumor Progression Locus 2 Serine/Threonine Kinase, Inhibits Tumor Necrosis Factor-α-Induced Cyclooxygenase-2 Expression in JB6 Mouse Epidermis Cells
- Luteolin enhances the bioavailability of benzo(a)pyrene in human colon carcinoma cells
- Luteolin exerts an anticancer effect on gastric cancer cells through multiple signaling pathways and regulating miRNAs
- Luteolin inhibits recruitment of monocytes and migration of Lewis lung carcinoma cells by suppressing chemokine (C–C motif) ligand 2 expression in tumor-associated macrophage
- Inhibition of p300 lysine acetyltransferase activity by Luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model
- Potentiation of Luteolin cytotoxicity by flavonols fisetin and quercetin in human chronic lymphocytic leukemia cell lines
- Luteolin sensitizes the antiproliferative effectof interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells
- Induction of Endoplasmic Reticulum Stress via Reactive Oxygen Species Mediated by Luteolin in Melanoma Cells
- Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells
- Effects of Luteolinon arylamine N-acetyltransferase activity in human liver tumour cells.
- Evaluation of the antioxidant and anti-inflammatory nature of Luteolin in experimentally induced hepatocellular carcinoma
- Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats
- HIF‐1α/VEGF signaling‐mediated epithelial–mesenchymal transition and angiogenesis is critically involved in anti‐metastasis effect of Luteolin in melanoma cells
- Luteolin induces intrinsic apoptosis via inhibition of E6/E7 oncogenes and activation of extrinsic and intrinsic signaling pathways in HPV-18-associated cells
- Protein Kinase C Inhibition and X-Linked Inhibitor of Apoptosis Protein Degradation Contribute to the Sensitization Effect of Luteolin on Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis in Cancer Cells
- Synergistic anti-tumor actions of Luteolin and silibinin prevented cell migration and invasion and induced apoptosis in glioblastoma SNB19 cells and glioblastoma stem cells
- Natural Luteolin from Methanolic Extract of Malaysian Brucea javanica Leaves Induces Apoptosis in HeLaCell Lines
- Luteolin suppresses tumor proliferation through inducing apoptosisand autophagy via MAPK activation in glioma
- Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway
- Luteolinsensitizes Fas/FasL-induced apoptosis in HepG2 cellsthrough inhibiting Akt Activation and promoting XIAP Degradation
- Inhibitory Effect of Flavonoid Luteolin on 6-Hydroxydopamine Cytotoxicity via Suppression of Apoptosis-Related Protein Activation
- Luteolin induces cholangiocarcinoma cell apoptosisthrough the mitochondrial‐dependent pathway mediated by reactive oxygen species
- Luteolin inhibits proliferation of human glioblastoma cells via induction of cell cycle arrest and apoptosis
- Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells
- Mechanism of Luteolin–induced apoptosis through suppressing p21(WAF1/CIP1) expression with rapamycin in HER2-overexpressing cancer cells
- LuteolinDecreases Epidermal Growth Factor Receptor‐Mediated Cell Proliferation and Induces Apoptosis in Glioblastoma Cell Lines
- Cytotoxic Effect of Luteolin on Human Colorectal Cancer Cell Line (HCT-15): Crucial Involvement of Reactive Oxygen Species
- Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and Luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
- Induction apoptosis of Luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK
- Distinct mechanisms of DNA damage in apoptosisinduced by quercetin and Luteolin
- Luteolin induces myelodysplastic syndrome‑derived cell apoptosis via the p53‑dependent mitochondrial signaling pathway mediated by reactive oxygen species
- Effects of Luteolin on the inhibition of proliferation and induction of apoptosis in human myeloid leukaemia cells
- Luteolin sensitizes tumor necrosis factor-α-induced apoptosis in human tumor cells
- Induction of apoptosis by Luteolin through cleavage of Bcl-2 family in human leukemia HL-60 cells
- Pro-apoptotic effects of the flavonoid Luteolin in rat H4IIE cells
- Luteolin induced DNA damage leading to human lung squamous carcinoma CH27 cell apoptosis
- Luteolin induces apoptosis through endoplasmic reticulum stress and mitochondrial dysfunction in Neuro-2a mouse neuroblastoma cells
- Luteolin Inhibits Apoptosis and Improves Cardiomyocyte Contractile Function through the PI3K/Akt Pathway in Simulated Ischemia/Reperfusion
- Luteolin ameliorates cisplatin-induced acute kidney injury in mice by regulation of p53-dependent renal tubular apoptosis
- Flavonoid quercetin, but not apigenin or Luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants.
- Luteolin improves contractile function and attenuates apoptosis following ischemia–reperfusion in adult rat cardiomyocytes
- Luteolin ameliorates cisplatin-induced nephrotoxicity in mice through inhibition of platinum accumulation, inflammation and apoptosis in the kidney
- Targeting Cell Signaling and Apoptotic Pathways by Luteolin: Cardioprotective Role in Rat Cardiomyocytes Following Ischemia/Reperfusion
- Induction of endoplasmic reticulum stress-mediated apoptosis and non-canonical autophagy by Luteolin in NCI-H460 lung carcinoma cells
- Luteolin Induces Mitochondria-dependent Apoptosis in Human Lung Adenocarcinoma Cell
- Luteolinsynergizes the antitumor effects of 5-fluorouracil against human hepatocellular carcinoma cells through apoptosis induction and metabolism
- Luteolin Arrests Cell Cycling, Induces Apoptosisand Inhibits the JAK/STAT3 Pathway in Human Cholangiocarcinoma Cells
- Luteolin Induces Carcinoma Cell Apoptosis through Binding Hsp90 to Suppress Constitutive Activation of STAT3
- Luteolin Inhibits Lysophosphatidylcholine-Induced Apoptosis in Endothelial Cells by a Calcium/Mithocondrion/Caspases-Dependent Pathway
- Caspase Activation and Extracellular Signal‐Regulated Kinase/Akt Inhibition Were Involved in Luteolin‐Induced Apoptosis in Lewis Lung Carcinoma Cells
- Luteolin, an Abundant Dietary Component is a Potent Anti-leishmanial Agent that Acts by Inducing Topoisomerase II-mediated Kinetoplast DNA Cleavage Leading to Apoptosis
- Leishmania donovani: Intracellular ATP level regulates apoptosis-like death in Luteolin induced dyskinetoplastid cells
- Anti-hepatoma cells function of Luteolin through inducing apoptosis and cell cycle arrest
- Protective Effects of Luteolin against Apoptotic Liver Damage Induced by d-Galactosamine/Lipopolysaccharide in Mice
- Abstract #2672: Quercetin, Luteolin and ursolic acid are potent inducers of apoptosis in colorectal carcinoma cells: interaction with 5-Fluoracil
- Luteolin Induced-growth Inhibition and Apoptosisof Human Esophageal Squamous Carcinoma Cell Line Eca109 Cells in vitro
- Luteolin Promotes Cell Apoptosis by Inducing Autophagy in Hepatocellular Carcinoma
- Luteolin sensitizes human 786-O renal cell carcinoma cells to TRAIL-induced apoptosis
- Luteolin Attenuates Foam Cell Formation and Apoptosis in Ox-LDL-Stimulated Macrophages by Enhancing Autophagy
- Comparative Studies to Evaluate Relative in vitro Potency of Luteolin in Inducing Cell Cycle Arrest and Apoptosis in HaCaT and A375
- Luteolin Induces Apoptosis via Mitochondrial Pathway and Inhibits Invasion and Migration of Oral Squamous Cell Carcinoma by Suppressing Epithelial-Mesenchymal Transition Induced Transcription Factors
- Luteolin‑induced protection of H2O2‑induced apoptosis in PC12 cells and the associated pathway
- Luteolin induces apoptosis by ROS/ER stress and mitochondrial dysfunction in gliomablastoma
- Luteolin inhibits cell proliferation and induces cell apoptosis via down-regulation of mitochondrial membrane potential in esophageal carcinoma cells EC1 and KYSE450
- Luteolin inhibits SH-SY5Y cell apoptosis through suppression of the nuclear transcription factor-κB, mitogen‑activated protein kinase and protein kinase B pathways in lipopolysaccharide-stimulated cocultured BV2 cells
- Induction of Apoptosis by Luteolin Involving Akt Inactivation in Human 786-O Renal Cell Carcinoma Cells
- Luteolin Inhibits Proliferation and Induces Apoptosis of Human Placental Choriocarcinoma Cells by Blocking the PI3K/AKT Pathway and Regulating Sterol Regulatory Element Binding Protein Activity
- Luteolin inhibits pyrogallol-induced apoptosis through theextracellular signal-regulated kinase signaling pathway
- Protective effect of Luteolin on cigarette smoke extract‑induced cellular toxicity and apoptosis in normal human bronchial epithelial cells via the Nrf2 pathway
- Molecular Mechanisms ofLuteolin Induced Growth Inhibition and Apoptosis of Human Osteosarcoma Cells
- Pyrrolidine Dithiocarbamate Inhibition of Luteolin–Induced Apoptosis through Up-regulated Phosphorylation of Akt and Caspase-9 in Human Leukemia HL-60 Cells
- Protective Effects of Luteolin against Amyloid β25–35-induced Toxicity on Rat Cerebral Microvascular Endothelial Cells
- Protective Effects of Luteolin-7-O-β-D-glucopyranoside on Hypoxic-ische mic Injury of Myocardial Cells in Neonatal Rats
- Luteolin Prevents H2O2-Induced Apoptosis in H9C2 Cells through Modulating Akt-P53/Mdm2 Signaling Pathway
- Caspase Activation and Extracellular Signal‐Regulated Kinase/Akt Inhibition Were Involved in Luteolin‐Induced Apoptosis in Lewis Lung Carcinoma Cells
- Luteolin Induces Apoptosis, G0/G1 Cell Cycle Growth Arrest and Mitochondrial Membrane Potential Loss in Neuroblastoma Brain Tumor Cells
- Luteolin–induced apoptosisthrough activation of endoplasmic reticulum stress sensors in pheochromocytoma cells
- Luteolin INDUCES APOPTOSIS IN AZOXYMETHANE-INDUCED COLON CARCINOGENESISTHROUGH THE INVOLVEMENT OF BCL-2, BAX AND CASPASE-3
- Inhibition of α-Synuclein contributes to the ameliorative effects of dietary flavonoids Luteolin on arsenite-induced apoptotic cell death in the dopaminergic PC12 cells
- Increase of Bax/ Bcl-XL ratio and arrest of cell cycle by Luteolin in immortalized human hepatoma cell line
- The Flavonoid Luteolin Increases the Resistance of Normal, but Not Malignant Keratinocytes, Against UVB-Induced Apoptosis
- Luteolin induces apoptosis by activating Fas signaling pathway at the receptor level in laryngeal squamous cell line Hep-2 cells
- Gallic Acid Induces Apoptosis via Caspase-3 and Mitochondrion-Dependent Pathways in Vitro and Suppresses Lung Xenograft Tumor Growth in Vivo
- Luteolinsupplementation adjacent to aspirin treatment reduced dimethylhydrazine-induced experimental colon carcinogenesis in rats
- The Flavone Luteolin Improves Central Nervous System Disordersby Different Mechanisms: A Review
- Luteolinprevents palmitic acid-induced hepatic steatosis by regulating ER stress in HepG2
- Liposome encapsulated Luteolin showed enhanced antitumor efficacy to colorectal carcinoma
- Protective Effect of Luteolin against β-Amyloid-induced Cell Death and Damage in BV-2 Microglial Cells
- Luteolin inhibits cell cycle progression andinduces apoptosis of breast cancer cellsthrough downregulation of human telomerase reverse transcriptase
- Luteolin modulates gene expression related to steroidogenesis, apoptosis, and stress response in rat LC540 tumor Leydig cells
- Luteolin Decreases EGFR-Mediated Cell Proliferation andInduces Apoptosis in Glioblastoma Cell Lines.
- Luteolin inhibits multi-heavy metal mixture-induced HL7702 cell apoptosisthrough downregulation of ROS-activated mitochondrial pathway
- Pyrrolidine Dithiocarbamate (PDTC) Attenuates Luteolin–Induced Apoptosis in Human Leukemia HL-60 Cells
- Effect and mechanism ofluteolin on cardiac protection and anti-apoptosis in rat cardiomyocytes with ischemia-reperfusion injury
- THE NATURAL FLAVONOID Luteolin INDUCES APOPTOSIS IN COLON CANCER CELLSBY DYSREGULATING THE SPHINGOLIPID RHEOSTAT
- The apoptosis of HepG2 cells and effect of C-jun N-terminal kinase signaling pathway induced by Luteolincombined with cisplatin
- Novel synthetic Luteolin analogue-caused sensitization of tumor necrosis factor-α-induced apoptosis in human tumor cells
- Luteolin Regulates Macrophage Polarization via the PI3K/Akt Pathway to Inhibit the Apoptosis Stimulated by Angiotensin II
- Luteolin Induces Apoptosis and Autophagy in Mouse Macrophage ANA-1 Cells via the Bcl-2 Pathway
- Stimulation of Fas/FasL‐mediated apoptosis by Luteolin through enhancement of histone H3 acetylation and c‐Jun activation in HL‐60 leukemia cells
- Luteolin induces caspase-dependent apoptosis via inhibiting the AKT/osteopontin pathway in human hepatocellular carcinoma SK-Hep-1 cells
- GW26-e4771 Protective and antiapoptotic effects of Luteolin on oxidative injury in H9C2 cardiomyocytes
- Protection of Luteolin-7-O-glucoside against apoptosis induced by hypoxia/reoxygenation through the MAPK pathways in H9c2 cells
- Studies on the Mechanism of Luteolin–induced Apoptosis in Breast Cancer Cell
- Luteolin attenuates diabetes-associated cognitive decline in rats
- Luteolin Ameliorates Cognitive Impairmentsby Suppressing the Expression of Inflammatory Cytokines and Enhancing Synapse-Associated Proteins GAP-43 and SYN Levels in Streptozotocin-Induced Diabetic Rats
- Identification of an Inhibitory Mechanism of Luteolin on the Insulin‐Like Growth Factor‐1 Ligand–Receptor Interaction
- Combination of Luteolin and Solifenacin Improves Urinary Dysfunction Induced by Diabetic Cystopathy in Rats
- Chrysin and Luteolin Attenuate Diabetes‐Induced Impairmentin Endothelial‐Dependent Relaxation: Effect on Lipid Profile, AGEs and NO Generation
- Protective Effects of Luteolin on Diabetic Nephropathy in STZ-Induced Diabetic Rats
- Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress
- Luteolin ameliorates cardiac failure in type I diabetic cardiomyopathy
- Cardioprotective effects of luteolin on ischemia/reperfusion injury in diabetic rats are modulated by eNOS and the mitochondrial permeability transition pathway.
- Luteolin Limits Infarct Size and Improves Cardiac Function after Myocardium Ischemia/Reperfusion Injury in Diabetic Rats
- Anti-diabetic effectsof Luteolin and Luteolin-7-O-glucoside on KK-Ay mice
- Luteolin, a Flavone, Does Not Suppress Postprandial Glucose Absorption Through an Inhibition of α-Glucosidase Action
- Luteolin inhibits adipogenic differentiation by regulating PPARγ activation
- Effects of Luteolin 5-O-β-rutinoside in streptozotocin-induced diabetic rats
- Low‐dose diet supplement of a natural flavonoid, Luteolin, ameliorates diet‐induced obesity and insulin resistance in mice
- Luteolin inhibits inflammatory response and improves insulin sensitivityin the endothelium
- Effects of Luteolin on retinal oxidative stress and inflammation in diabetes
- Ursolic acid and Luteolin‐7‐glucoside improve lipid profiles and increase liver glycogen content through glycogen synthase kinase‐3
- Luteolin Attenuates Hepatic Steatosis and Insulin Resistance Through the Interplay Between the Liver and Adipose Tissue in Mice with Diet-Induced Obesity
- Luteolin protects against high fat diet-induced cognitive deficits in obesity mice
- Luteolin improves the impaired nerve functions in diabetic neuropathy: behavioral and biochemical evidences
- Luteolin Inhibits Hyperglycemia‐Induced Proinflammatory Cytokine Production and Its Epigenetic Mechanism in Human Monocytes
- Effects of Luteolin on aldose reductase,NOS system and Na~+-K~+-ATPase in cardiac muscles of early diabetes rats
- Luteolin enhances insulin sensitivity via activation of PPARγ transcriptional activity in adipocytes
- Chrysin and Luteolin Alleviate Vascular Complications Associated with Insulin Resistance Mainly Through PPAR-γ Activation
- Luteolin prevents uric acid-induced pancreatic β-celldysfunction
- Evaluation of the Wound Healing Properties of Luteolin Ointments on Excision and Incision Wound Models in Diabetic and Non-Diabetic Rats
- Luteolin reduces obesity-associated insulin resistance in mice by activating AMPKα1 signalling in adipose tissue macrophages
- Determination of antioxidant and α-glucosidase inhibitory activities and Luteolin contents of Chrysanthemum morifolium Ramat extracts
- Opposite Effects of Quercetin, Luteolin, and Epigallocatechin Gallate on Insulin Sensitivity Under Normal and Inflammatory Conditions in Mice
- Combination Treatments with Luteolin and Fisetin Enhance Anti-Inflammatory Effects in High Glucose-Treated THP-1 CellsThrough Histone Acetyltransferase/Histone Deacetylase Regulation
- Protective effect of Luteolin on streptozotocin-induced diabetic renal damage in mice via the regulation of RIP140/NF-кB pathway and insulin signalling pathway
- Quercetin, Luteolin, and Epigallocatechin Gallate Promote Glucose Disposal in Adipocytes with Regulation of AMP-Activated Kinase and/or Sirtuin 1 Activity
- Luteolin protect against diabetic cardiomyopathy in rat model via regulating the AKT/GSK-3α signalling pathway
- [Luteolin reduces cardiac dysfunctions in streptozotocin-induced diabetic rats].
- Luteolin improves non-alcoholic fatty liver disease in db/db mice by inhibition of liver X receptor activation to down-regulate expression of sterol regulatory element binding protein 1c
- Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity
- The Falconoid Luteolin Mitigates the Myocardial Inflammatory Response Induced by High-Carbohydrate/High-Fat Diet in Wistar Rats
- Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses
- Anti-degenerative effect of Apigenin, Luteolin and Quercetin on human keratinocyte and chondrocyte cultures: SAR evaluation
- Protective effects of Luteolin on STZ-induced diabetic kidneys
- Structure-Activity Relationship Study Reveals Benzazepine Derivatives of Luteolin as New Aldose Reductase Inhibitors for Diabetic Cataract
- Wound healing effect of flavonoid rich fraction and Luteolin isolated from Martynia annua Linn. on streptozotocin induced diabetic rats
- The Studies on the protective effect of Luteolin on kidney in diabetic Rats
- Tissue Specific Action of PPARγ as a Mediator of the Metabolic Response to Flavonoid Luteolin in Diet-Induced Obesity
- Actions of Luteolin on Regulation of Overweight Metabolic Stressthrough the Interplay between the Liver and Adipose Tissue
- Effect of luteoin in delaying cataract in STZ-induced diabetic rats
- Luteolin Limits Infarct Size and Improves CardiacFunction after MyocardiumIschemia/Reperfusion Injury in Diabetic Rats
- Can Luteolin be a therapeutic molecule for both colon cancer and diabetes?
- Luteolin protects against high fat diet-induced cognitive deficits in obesity mice
- Flavonoids diosmetin and Luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes
- Brain “fog,” inflammation and obesity: key aspects of neuropsychiatric disorders improved by Luteolin
- Luteolin Attenuates Hepatic Steatosis and Insulin Resistance Through the Interplay Between the Liver and Adipose Tissue in Mice with Diet-Induced Obesity
- Low‐dose diet supplement of a natural flavonoid, Luteolin, ameliorates diet‐induced obesity and insulin resistance in mice
- Luteolin reduces obesity-associated insulin resistance in mice by activating AMPKα1 signalling in adipose tissue macrophages
- Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity
- Luteolin-Enriched Artichoke Leaf Extract Alleviates the Metabolic Syndrome in Mice with High-Fat Diet-Induced Obesity
- Luteolin Targets the Toll-Like Receptor Signaling Pathway in Prevention of Hepatic and Adipocyte Fibrosis and Insulin Resistance in Diet-Induced Obese Mice
- Luteolin Supplementation Modulates Mammary Tumor Growth in C3H Mice